The Firm represented JPMorgan Chase Bank, N.A. and Morgan Stanley Senior Funding, Inc., as lead arrangers, in connection with Thermo Fisher Scientific Inc.’s €3 billion term loan facility, the amendment of its existing bridge credit facility and the amendment and extension of its existing revolving credit facility. The proceeds of the term loan facility will be available to finance the tender offer to acquire the ordinary shares of Qiagen trading in Frankfurt and New York and to pay fees and expenses related thereto.
Thermo Fisher, the world leader in serving science, has more than 75,000 employees and serves customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental, industrial quality and process control industries. Qiagen is a Dutch company headquartered in Germany and leading global provider of molecular diagnostics and sample preparation technologies.
The Simpson Thacher team included Patrick Ryan, Christine Marshall and Libby Pica (Banking and Credit); Marcy Geller and Morgan Otway (Tax); and Andrew Blau and Jeanne Annarumma (ECEB).